Article
Integrating Tuberculosis and COVID-19 Molecular Testing in Lima, Peru
2022-07-27
Abstract excerpt
Background: Tuberculosis case notifications have plummeted since the COVID-19 pandemic began. Integrated molecular testing could be an opportunity to detect and provide care for both diseases. Many high tuberculosis burden countries have existing GeneXpert networks for tuberculosis testing using Xpert MTB/RIF Ultra (Ultra), and a GeneXpert SARS-CoV-2 assay, Xpert Xpress SARS-CoV-2 (Xpress), is also available. We a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 16cffebf-9b86-513d-9cee-fd9d5cf59f29
- DOI
- 10.2139/ssrn.4174292
